Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 21, 2025
Synfini Inc. and Multispan Announce Drug Discovery Collaboration
GlobeNewswire
·
May 21, 2025
MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., the leader in AI-driven agile chemistry for better molecule discovery, announced today that it has entered a collaboration with biotechnology company Multispan to co-discover and develop …
Carestream Launches Carestream 360º: A New Analytics Dashboard for Streamlined Reporting and Deeper Operational Insight
GlobeNewswire
·
May 21, 2025
Rochester, N.Y., May 21, 2025 (GLOBE NEWSWIRE) -- Carestream Health today announced the U.S. market launch of Carestream 360º, an advanced analytics dashboard designed to help radiology departments track key performance metrics, analyze imaging trends, and …
ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease
GlobeNewswire
·
May 21, 2025
Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa initiation as an endpoint to measure trial success, which Company believes is a direct measure of …
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
GlobeNewswire
·
May 21, 2025
Conduit regains compliance with Bid Price and Equity Requirements CDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) …
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
GlobeNewswire
·
May 21, 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies for specialists and community care providers, that address important …
Proto Hologram Inventor named to TIME100 Health List
GlobeNewswire
·
May 21, 2025
New York, New York, May 21, 2025 (GLOBE NEWSWIRE) -- TIME has named David Nussbaum, Founder and Chairman of Proto Inc., to its 2025 TIME100 Health list in the "Innovators" category, recognizing his pioneering work creating hologram and AI technology to …
Introducing Professional Dental Services from Meader Family Dentistry
EIN Presswire
·
May 21, 2025
Meader Family Dentistry Now Offers Trusted Dental Care for the Whole Family VIRGINIA, VA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Meader Family Dentistry is excited to introduce a comprehensive range of professional dental services to meet the …
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 21, 2025
WALTHAM, Mass., May 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network
GlobeNewswire
·
May 21, 2025
FORT MYERS, Fla., May 21, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it is expanding access to cutting-edge radioligand therapies (RLT), providing more patients …
Soleno Therapeutics to Participate in Upcoming June Conferences
GlobeNewswire
·
May 21, 2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the …
Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 21, 2025
ORANGE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, at 2 p.m. CDT. A webcast and replay of the …
Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025
GlobeNewswire
·
May 21, 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a …
Konica Minolta Healthcare to Launch Integrated Teleradiology Solution Powered by NewVue
GlobeNewswire
·
May 21, 2025
TAMPA, Fla. and WAYNE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a pioneer in imaging and healthcare IT innovation, and NewVue, the leading provider of intelligent, cloud-native radiology workflow solutions, today …
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
GlobeNewswire
·
May 21, 2025
Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment of platinum resistant ovarian cancer (PROC) with expansion opportunities into endometrial, uterine …
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
GlobeNewswire
·
May 21, 2025
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery of the super-bore HiPoint 88 Reperfusion System to MI occlusions and 84% first pass …
Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease
GlobeNewswire
·
May 21, 2025
Maintains Brain Connectivity: GAL-201 prevents amyloid-beta (Aβ)–induced synaptic damage by maintaining long-term potentiation, a correlate for learning and memory. Improves Memory and Behavior: Preclinical testing shows significant improvements in spatial …
The Beauty Health Company Announces Convertible Debt Refinancing
GlobeNewswire
·
May 21, 2025
LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreements (the “Exchange Agreements”) with certain …
Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal
GlobeNewswire
·
May 21, 2025
CINCINNATI, May 21, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider focused on end-to-end respiratory care, today announced that it has received an …
All Three Leading Proxy Advisory Firms – ISS, Glass Lewis, and Egan-Jones – Recommend Zevra Stockholders Vote FOR the Company’s Director Nominees
GlobeNewswire
·
May 21, 2025
ISS, Glass Lewis, and Egan-Jones Unanimously Conclude Mangless Has Not Made a Compelling Case for Change Board and Management Urge Stockholders to Follow Proxy Advisors’ Recommendation and Vote “FOR” Wendy L. Dixon, Ph.D. and Tamara A. Favorito on the …
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
GlobeNewswire
·
May 21, 2025
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of …